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Abstract
Background The aim of this study was to evaluate the safety, effectiveness, and health-related QOL impact of early reha-
bilitation in patients with nephrotic syndrome.
Methods Subjects consisted of 23 patients with nephrotic syndrome who had previously received steroid treatment. Patients 
worked performed quadriceps resistance training and aerobic training 5 days per week for 5 weeks. Urinary protein, albumin 
(Alb), creatinine (Cre), and blood urea nitrogen (BUN) were monitored once every week over a 5-week period based on 
medical records. The 36-item short form health survey (SF-36) score was used to evaluate health-related QOL.
Results There was no significant difference in quadriceps force and no significant effect of age as shown by ANCOVA. 
Anaerobic threshold (AT) and peak oxygen consumption (peak VO2) both increased significantly. AT was affected by the 
degree of change in body weight according to ANCOVA. Cre and BUN were not significantly altered. Urinary protein showed 
a significant decrease and Alb was significantly increased. Only physical function (PF) in the SF-36 showed a significant 
improvement following the intervention.
Conclusion Our data indicate that early rehabilitation involving quadriceps resistance training and aerobic training for 
nephrotic syndrome is safe and effective.
Keywords Nephrotic syndrome · Rehabilitation · Aerobic training · Quadriceps resistance training
Introduction
In Japan, approximately 13.3 million adults experience 
chronic kidney disease (CKD) according to a survey by the 
Japan Society of Nephrology [1]. Many patients show pro-
longed survival due to high healthcare standards in dialysis. 
Patients with CKD and undergoing dialysis demonstrate 
decreased physical exercise [2, 3], and a comprehensive 
program of kidney rehabilitation has been recommended 
for patients with disorders related to renal diseases and 
dialysis [4]. Accumulating evidence in kidney rehabilita-
tion suggests an improvement of malnutrition–inflammation 
complex syndrome [5], promotion of assimilation of muscle 
protein [6], improvement of quality of life [7], and improve-
ment of exercise capacity [8]. Most of these studies included 
patients with stable CKD and regular dialysis, rather than 
acute cases. There are no clear guidelines for acute cases; 
thus, there is a need for additional evidence regarding the 
effect of kidney rehabilitation on acute onset renal disease.
According to nephrotic syndrome guidelines in Japan, 
excessive rest is not advisable because a long period of bed 
rest increases the risk of deep vein thrombosis and pulmo-
nary embolism [9]. This suggests that rest is a relative risk 
factor, and there is no clear statement on the safety and effi-
cacy of early rehabilitation for nephrotic syndrome.
The purpose of this study is to examine the safety and 
effectiveness of an early common intervention approach 
involving 5 weeks of quadriceps resistance training and 
aerobic training in patients with nephrotic syndrome who 
received steroid treatment.
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Methods
Study design
Prospective observational study.
Participants
Thirty patients diagnosed with nephrotic syndrome 
received steroid treatment at our hospital, of which seven 
patients were discharged prior to completing the study. 
A total of 23 patients (age 52.4 ± 23.5 years; 14 men, 9 
women) were enrolled. None of the patients were receiv-
ing dialysis treatment and all patients lived independently. 
Steroid treatment was started a dose of 45–60 mg, adjusted 
for patient age and weight. Rehabilitation for prevention 
of thrombosis and disuse syndrome was started under the 
direction of a doctor. The doctor and physical therapist 
performed evaluations by direct monitoring and indirectly 
using blood tests and urinalysis to ensure safety. Subjects 
were hospitalized and were provided supervised meals by 
a nutritionist. Baseline characteristics of the patients at 
the time of hospital admission are shown in Table 1. Of 
the 23 patients, 12 patients had minimal change nephrotic 
syndrome (MCNS), 9 patients had membranous nephrop-
athy (MN), 1 patient had lupus nephritis, and 1 patient 
had rapidly progressive glomerulonephritis. All patients 
underwent renal biopsy and then started steroid treatment, 
followed by rehabilitation. Twelve patients received ster-
oid treatment only, nine patients received steroid treatment 
and immunosuppressive therapy, and two patients received 
steroid treatment, immunosuppressive therapy, and LDL 
apheresis.
Study protocol
All patients started rehabilitation promptly after steroid 
treatment, and measurement results were recorded for each 
patient. The study protocol consisted of resistance training 
and aerobic training performed 5 days per week for 5 weeks. 
The detailed protocol for this study was as follows.
Protocol 1
Isometric quadriceps force was measured using an iso-
metric dynamometer (Isoforce GT-360, OG Wellness Co., 
Okayama, Japan). During the assessment, the foot was not 
weight bearing and the knee was passively drawn into 60° 
flexion by gravity. A soft cuff, attached via an adjustable 
non-elastic metal cord to a load cell, was fitted with Velcro 
just above the ankle. The isometric quadriceps force was 
measured twice for 3 s after practicing once, and the greater 
value was recorded [10]. Quadriceps resistance training in 
elderly people can be effective even at a low load [11]. After 
we measured the maximum quadriceps force, quadriceps 
resistance training with a load of 40–60% of the maximum 
quadriceps force, depending on the age of the patient, was 
performed using a dedicated machine (Leg Extension FS-50, 
Paramount, Los Angeles, CA, US). Subjects performed one 
set of ten repetitions during the machine training session in a 
seated position. Repetition consisted of a two-count concen-
tric (lifting) phase, a slight pause, and a four-count eccentric 
(lowering) phase [5]. The frequency of training was adjusted 
for medium or higher fatigue, and training occurred 5 days 
per week for 5 weeks. Patients performed 20-min sessions 
of quadriceps resistance training, and maximum quadri-
ceps force was measured initially and again after 5 weeks. 
Weight loss during the intervention was primarily a decrease 
in hydration due to diuresis. The quadriceps force was not 
divided by body weight, but rather was divided by the length 
of the lower limb (Nm).
Protocol 2
For cardiopulmonary exercise testing (CPET), patients 
were instructed to exercise maximally to symptomatic end-
points measured using an isokinetic ergometer (Aerobike 
75XL, Minato Medical Science Co. Ltd., Osaka, Japan). A 
mask was placed covering the nose and the mouth, and the 
patient breathed through a non-rebreathing valve. Air was 
delivered to an  O2 and  CO2 analyzer (Aeromonitor 300S, 
Minato Medical Science Co. Ltd., Osaka, Japan). Breath-
by-breath gas exchange measurement was performed, 
Table 1  Baseline characteristics of the patients at hospitalization
Characteristics of the subjects are shown as mean ± SD in the para-
metric data, and median in the non-parametric data
BMI body mass index, BUN blood urea nitrogen, CRP C-reactive pro-
tein, IQR interquartile range
All patients (n = 23)
Age (years) 52.4 ± 23.5
Gender (Men, %) 14 (60.9%)
Height (cm) 161.2 ± 7.7
Weight (kg) 61.9 ± 8.9
BMI (kg/m2) 23.9 ± 3.6
Creatinine (mg/dl) 0.9 ± 0.3
BUN (mg/dl)
 Median (IQR) 18.4 (13.0–24.0)
Albumin (g/dl) 1.8 ± 0.6
Urinary protein (g/gCre) 10.2 ± 4.6
CRP (mg/dl)
 Median (IQR) 0.08 (0.30–0.15)
Clinical and Experimental Nephrology 
1 3
permitting continuous measurements of ventilation (VE), 
oxygen uptake (VO2), and  CO2 production (VCO2) on-line. 
The instrument was calibrated using reference gases before 
every test. During the test, a standard 12-lead ECG (Case, 
GE Healthcare, Wauwatosa, WI, US) was interfaced and 
heart rhythm was monitored continuously throughout the 
exercise test. Blood pressure was measured using a standard 
cuff sphygmomanometer at 1-min intervals. After station-
ary warm-up exercise at an equivalent of 15 W for 3 min, a 
ramp protocol with incremental steps equivalent to 20 W/
min was used at a rate of approximately 50 rotations/min 
[12]. In addition, elderly subjects performed at 10 W/min. 
All subjects performed a cool-down, at the initial workload 
of the exercise protocol, for at least 3 min after the cessa-
tion of ramping exercise. From the ventilator data, anaerobic 
threshold (AT) and peak oxygen consumption (peak VO2) 
were calculated. AT was measured by V-slope analysis and 
peak VO2 was expressed as the highest attained VO2 during 
the final ramping exercise. Exercise tests were supervised 
by an expert team consisting of a doctor and physical thera-
pist. Patients underwent 15–20-min aerobic training sessions 
(Watt; AT-1 min) and training occurred 5 days per week 
for 5 weeks. CPET was measured initially and again after 
5 weeks.
Protocol 3
For renal function, in addition to the basic information at 
hospital admission, urinary protein, albumin (Alb), creati-
nine (Cre), and blood urea nitrogen (BUN) were assessed 
once per week for 5 weeks based on medical records. Mean 
urine protein excretion was determined as the average 
amount of urinary protein excretion over 5 weeks.
Protocol 4
The 36-item short form health survey (SF-36) score was 
used to evaluate health-related quality of life (HRQOL) [13]. 
The SF-36 is a comprehensive scale for the measurement 
of HRQOL via a self-administered questionnaire and con-
sists of 8 subscales comprising physical functioning (PF), 
role physical (RP), bodily pain (BP), general health (GH), 
vitality (VT), social functioning (SF), role emotional (RE), 
and mental health (MH). Assessments were performed at 
baseline and again after 5 weeks.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statis-
tics 22 (IBM, New York, NY, US). Results were consid-
ered statistically significant if the two-tailed P value was 
less than 0.05. Data are shown as the mean ± SD, except for 
non-normally distributed variables, which are shown as the 
median. Baseline comparisons between body weight, quadri-
ceps force, AT, and peak VO2 were performed using paired 
t test after examining normally distributed variables by the 
Shapiro–Wilk test. Quadriceps force was adjusted for age, 
and AT and peak VO2 were adjusted for the degree of change 
in body weight by ANCOVA. Spearman’s correlation analy-
sis of both groups combined was performed to determine the 
association between mean urinary protein excretion and the 
degree of change in quadriceps force. Alb, Cre, BUN, and 
urinary protein excretion over the 5 weeks of the study were 
examined by repeated one-way ANOVA and Bonferroni test. 
Bonferroni correction was performed for non-normally dis-
tributed variables. For five cases in which the urinary protein 
did not decrease to 3.5 g/gCre or less over the 5 weeks, Alb, 
Cre, BUN, and urinary protein excretion were additionally 
examined. The eight subscales of the SF-36 were analyzed 
by t test or Wilcoxon signed rank test.
Results
All cases completed the training successfully, but only one 
case showed vagal reflex after CPET. The mean patient 
weight significantly decreased by 4.6 kg after intervention. 
Quadriceps force was increased by 7.8 Nm after interven-
tion, which was not a significant difference, and was not 
affected by age as determined by ANCOVA (p = 0.308, 
Table 2). AT and peak VO2 improved significantly after 
intervention. AT adjusted by the degree of change in body 
Table 2  Body weight, quadriceps force and cardiopulmonary exercise testing before and after intervention
Mean mean value, SD standard deviation, ANCOVA analysis of covariance
Before intervention After intervention p value ANCOVA p 
value for age
ANCOVA p value for 
amount of change in body 
weight
Body weight (kg) 56.7 ± 9.0 52.1 ± 7.4 < 0.001
Quadriceps force (Nm) 92.3 ± 30.3 98.3 ± 33.6 0.068 0.308
Anaerobic threshold (AT; ml/min/kg) 9.1 ± 3.6 10.8 ± 4.6 < 0.001 0.043
Peak oxygen consumption (Peak VO2; 
ml/min/kg)
15.4 ± 4.6 17.6 ± 5.6 < 0.001 0.158
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weight was improved according to ANCOVA (p = 0.043, 
Table 2). There was a negative correlation between mean 
urinary protein excretion and the degree of change in quadri-
ceps force (r = − 0.42, p = 0.047, Fig. 1). Cre and BUN were 
not significantly altered. Urinary protein showed a signifi-
cant decrease at each week after 2 weeks as compared with 
week 1. There was a significant decrease between week 2 
and 4, and between week 2 and 5. Alb was significantly 
increased at each week after 3 weeks as compared with the 
week 1, and, Alb was significantly increased at all weeks 
after week 3 compared with week 2, as well as between 
week 3 and 5 (Fig. 2). In the 5 cases where urinary protein 
did not decrease below 3.5 g/gCre during the intervention, 
renal function did not show a significant difference (Fig. 3). 
Eight subscales of the SF-36 were examined before and after 
intervention. Only PF showed significant improvement, 
while there was no significant difference with the other sub-
scales (Table 3).
Discussion
In our study, quadriceps resistance training and aerobic train-
ing were performed 5 days per week for 5 weeks to verify the 
effect of exercise in patients with nephrotic syndrome who 
received steroid treatment. Quadriceps force was not sig-
nificantly affected, but AT and peak VO2 showed significant 
improvement without deterioration of renal function due to 
early rehabilitation. We previously reported that this was 
related to urine protein excretion and the effect of muscle 
Fig. 1  Spearman’s correlation 
analysis between mean urinary 
protein excretion and degree 
of change in quadriceps force 
(Δquadriceps force). r = − 0.42; 
p = 0.047
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Fig. 2  Urinary protein and albumin over 5 weeks (a), creatinine and blood urea nitrogen (b), in patients with nephrotic syndrome
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strengthening [14], and the present study also showed a simi-
lar result. It is likely that muscle strengthening was achieved 
more readily when urine protein excretion was reduced. It 
was difficult to strengthen muscle as a result of inhibition 
of muscle protein assimilation by protein catabolism due to 
increased urine protein excretion. Because there were differ-
ences in the effect of quadriceps resistance training depend-
ing on the subjects, there was no significant difference in the 
average quadriceps force.
The increased oxygen intake and energy production by 
aerobic training contributed to the improvement of exercise 
capacity. However, AT and peak VO2 were divided by body 
weight in our analysis. In the case of nephrotic syndrome, 
decreased urinary protein, improvement of Alb to improve 
colloid osmotic pressure, increased intravascular volume, 
and the use of a diuretic resulted in increased urine out-
put and decreased body weight. The average body weight 
decreased by 4.6 kg during the study. Decreased body weight 
leads to an increase in AT and peak VO2. Therefore, AT and 
peak VO2 were adjusted for the degree of change in body 
weight by ANCOVA. AT showed a significant improvement 
and there was no effect of change in body weight. These 
results demonstrated training effects of early rehabilitation. 
However, whether the effect of quadriceps resistance train-
ing contributed to exercise capacity could not be demon-
strated in present study and remains to be addressed in a 
future study.
We performed blood tests and urinalysis to ensure 
safety with respect to renal function. Cre and BUN were 
not significantly affected during the intervention, while 
urinary protein showed a significant decrease. Alb was 
significantly increased along with the decrease in urinary 
protein. It is important to reduce proteinuria to delay pro-
gression to renal failure [15]. Safety was demonstrated by 
the absence of deterioration of renal function and increase 
of urinary protein during early intervention in patients 
with nephrotic syndrome. It has been reported that renal 
blood flow is not affected by aerobic training in healthy 
Fig. 3  Urinary protein and albumin over 5 weeks (a), creatinine and blood urea nitrogen (b), in patients with nephrotic syndrome at resistance to 
steroid treatment
Table 3  SF-36 scores (scoring 
method based on national 
standard value) before and after 
intervention
Mean mean value, SD standard deviation, median median value, IQR interquartile range, PF physical func-
tioning, RP role physical, BP bodily pain, GH general health perceptions, VT vitality, SF social function-
ing, RE role emotional, MH mental health
SF-36 Before intervention After intervention p value
Mean ± SD Median IQR Mean ± SD Median IQR
PF 42.1 ± 13.0 41.1 30.5–51.6 46.7 ± 11.1 48.1 44.6–55.1 0.019
RP 38.9 ± 15.8 46.1 32.4–56.2 37.2 ± 13.8 39.2 29.0–52.8 0.141
BP 47.6 ± 14.1 52.6 35.8–61.4 50.7 ± 11.7 52.6 40.2–61.4 0.953
GH 44.2 ± 9.1 40.8 37.0–51.6 45.0 ± 7.6 46.2 38.1–48.9 0.606
VT 45.3 ± 14.1 50.2 37.9–56.4 49.8 ± 9.8 50.2 41.0–56.4 0.756
SF 39.2 ± 16.1 50.5 30.8–57.1 36.4 ± 13.5 37.4 30.8–50.5 0.236
RE 44.9 ± 14.9 52.3 35.3–56.6 42.6 ± 12.7 43.8 35.3–56.6 0.426
MH 47.4 ± 13.0 51.8 41.1–57.1 49.3 ± 10.7 49.1 41.1–59.7 0.958
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subjects [16], which may also be the case in nephrotic syn-
drome. Conversely, Miura et al. [17] reported the recur-
rence of MCNS due to an excessive walking load. How-
ever, the safety of exercise at an aerobic level in patients 
with nephrotic syndrome was demonstrated in the present 
study. Previous reports suggest that hypoalbuminemia is 
a risk factor for thrombosis [18] and decreased efficacy of 
diuretics [19], but our results support the safety of early 
rehabilitation, in that Alb showed a significant improve-
ment throughout the duration of the study.
Certain types of patients with nephrotic syndrome show 
resistance to steroid treatment [20]. In refractory nephrotic 
syndrome, a sufficient effect is not observed even after 6 
months or more of standard treatment. In this study, cases 
in which urinary protein did not decrease below 3.5 g/g Cre 
during intervention were defined as refractory. In total, 5 
out of 23 cases fulfilled this criteria. Ji [21] demonstrated a 
trend for decreased urinary protein in response to treadmill 
exercise in a nephrotic mouse model. In our study, in which 
steroid treatment was performed in all cases, the possibility 
could not be excluded that steroid treatment masked harmful 
effects on renal function associated with early rehabilitation. 
Therefore, we reevaluated the change in renal function in 
five refractory cases that showed resistance to steroid treat-
ment. For these cases, there was no significant deteriora-
tion in renal function, urinary protein, and Alb throughout 
the duration of intervention. Even considering the effect of 
steroid treatment, quadriceps resistance training and aero-
bic training appeared to be safe in patients with nephrotic 
syndrome in this study. However, the applicability of these 
findings is limited due to the small number of cases studied.
Assessment of HRQOL in this study was performed using 
SF-36 scores before and after the intervention. Among the 
eight subscales of the SF-36, PF was significantly improved, 
while there were no significant differences in the other 
subscales. The effect on social and mental health was not 
expected. Many of the subjects in this study were of produc-
tive age, and it is possible that anxiety about work and life, 
and relapses of nephrotic syndrome after discharge may not 
have been resolved.
There were some limitations to the present study. First, 
the study lacked a control group and was performed at a 
small single center. Additionally, only a small number of 
subjects were studied and the 5-week observation period 
was relatively short. Further studies using a larger number 
of subjects and a longer period of observation are needed. 
Second, safety was demonstrated based on resistance train-
ing and aerobic training, which is generally regarded as 
safe even for early rehabilitation; however, it is unknown 
from this study how much of a load can be considered safe 
in patients with nephrotic syndrome. Third, it is necessary 
to verify our findings in cases of acute kidney injury by 
nephrotic syndrome, nephrotic syndrome in children, and 
acute cases not treated with steroids due to chronically 
decreased renal function.
Conclusion
The present study evaluated the effect of quadriceps resist-
ance training and aerobic training performed 5 days per week 
for 5 weeks in patients with nephrotic syndrome requiring 
steroid treatment. Blood tests showed no deterioration in 
renal function, urinalysis confirmed the safety of the inter-
vention, and significant improvement in exercise capacity 
by resistance and aerobic training was demonstrated. With 
respect to HRQOL, only PF showed significant improve-
ment, indicating an effect on physical QOL. Our results 
demonstrate that early rehabilitation with quadriceps resist-
ance training and aerobic training for nephrotic syndrome 
is safe and effective.
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